Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 18 of 18 entries
View as:

Clinical Study to Evaluate the Handling and Safety of AVT06 PFS in Subjects With Chorioretinal Vascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT05986786 Org: User:
Start: 02/28/24 End: 03/21/25 Due: 03/21/26

Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab)

Phase: N/A Priority: Normal
NCT ID: NCT04744363 Org: User:
Start: 05/25/21 End: 03/19/22 Due: 03/19/23

PK, Safety and Tolerability Study of AVT02 (Adalimumab) Pre-filled Syringe (PFS) vs, AVT02 Autoinjector (AI)

Phase: N/A Priority: Normal
NCT ID: NCT03983876 Org: User:
Start: 07/01/19 End: 12/03/19 Due: 12/03/20

Efficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03849404 Org: User:
Start: 02/20/19 End: 07/20/20 Due: 07/20/21

Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT04453137 Org: User:
Start: 06/30/20 End: 11/16/21 Due: 11/16/22

Comparative, Multicenter Study in Subjects with Rheumatoid Arthritis, ALVOFLEX

Phase: N/A Priority: Normal
NCT ID: NCT05842213 Org: User:
Start: 03/30/23 End: 09/24/24 Due: 09/24/25

Pharmacokinetics, Safety and Tolerability Study of AVT02 to EU-approved and US-licensed Humira (Adalimumab)

Phase: N/A Priority: Normal
NCT ID: NCT03849313 Org: User:
Start: 03/20/19 End: 02/17/20 Due: 02/17/21

AVT03 With Xgeva in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05876949 Org: User:
Start: 07/21/23 End: 04/15/24 Due: 04/15/25

Clinical Study to Compare Efficacy and Safety of AVT06 and EU-Eylea (ALVOEYE)

Phase: N/A Priority: Normal
NCT ID: NCT05155293 Org: User:
Start: 06/28/22 End: 09/23/24 Due: 09/23/25

Auto-injector Real Life Handling in Patients

Phase: N/A Priority: Normal
NCT ID: NCT04224194 Org: User:
Start: 11/04/19 End: 02/26/21 Due: 02/26/22

Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio

Phase: N/A Priority: Normal
NCT ID: NCT06570772 Org: User:
Start: 09/23/24 End: 08/31/26 Due: 08/31/27

Comparative Safety, Tolerability, Pharmacokinetic Study of AVT02 (100MG/ML) and Humira (100MG/ML) in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03579823 Org: User:
Start: 05/21/18 End: 08/24/18 Due: 08/24/19

A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05632211 Org: User:
Start: 12/16/22 End: 10/03/23 Due: 10/03/24

Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBOND

Phase: N/A Priority: Normal
NCT ID: NCT05395091 Org: User:
Start: 08/23/22 End: 10/28/24 Due: 10/28/25

Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT04930042 Org: User:
Start: 06/03/21 End: 10/11/22 Due: 10/11/23

Pilot Study of AVT16 in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06400719 Org: User:
Start: 05/29/24 End: 11/06/24 Due: 11/06/25

Study to Investigate Comparative Pharmacokinetics, Safety, Immunogenicity and Tolerability Between AVT80 and Entyvio

Phase: N/A Priority: Normal
NCT ID: NCT06732804 Org: User:
Start: 02/11/25 End: 10/31/25 Due: 10/31/26

AVT03 With Prolia in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05126784 Org: User:
Start: 06/29/22 End: 10/16/23 Due: 10/16/24